Regulation of collagenase activity in the ulcerating cornea by cyclic-AMP

Michael B. Berman; H. Dwight Cavanagh; Janet Gage

doi:10.1016/0014-4835(76)90048-8

Regulation of collagenase activity in the ulcerating cornea by cyclic-AMP

Michael B. Berman, H. Dwight Cavanagh, Janet Gage

Research output: Contribution to journal › Article › peer-review

13 Scopus citations

Abstract

Dibutyryl cyclic-AMP (DBcAMP) and theophylline partially inhibit the appearance of collagenase activity when added to cultures of ulcerating rabbit corneas. Drug treatment with DBcAMP also inhibits degradation of collagen in the explanted corneas as measured by hydroxyproline in the media. The hydrolysis product of DBcAMP, 5′-adenosine monophosphate (5′ AMP) is itself very effective in suppressing collagenase activity and the degradation of explant collagen. The mechanism(s) of the drug effects is not yet known but it is possible that the drugs affect the synthesis and/or the secretion of collagenase. The results suggest that "first messengers" exist which can prevent the secretion of corneal collagenase by raising endogenous cAMP in corneal cells through stimulation of the adenyl cyclase system. Eventual successful treatment of corneal ulceration might well require pharmacologic intervention at multiple levels: the biosynthesis, secretion, activation and activity of collagenase.

Original language	English (US)
Pages (from-to)	209-218
Number of pages	10
Journal	Experimental Eye Research
Volume	22
Issue number	3
DOIs	https://doi.org/10.1016/0014-4835(76)90048-8
State	Published - Mar 1976

ASJC Scopus subject areas

Ophthalmology
Sensory Systems
Cellular and Molecular Neuroscience

Access to Document

10.1016/0014-4835(76)90048-8

Cite this

@article{084ec999be714a08ae4f1d4d7a4b0e4e,

title = "Regulation of collagenase activity in the ulcerating cornea by cyclic-AMP",

abstract = "Dibutyryl cyclic-AMP (DBcAMP) and theophylline partially inhibit the appearance of collagenase activity when added to cultures of ulcerating rabbit corneas. Drug treatment with DBcAMP also inhibits degradation of collagen in the explanted corneas as measured by hydroxyproline in the media. The hydrolysis product of DBcAMP, 5′-adenosine monophosphate (5′ AMP) is itself very effective in suppressing collagenase activity and the degradation of explant collagen. The mechanism(s) of the drug effects is not yet known but it is possible that the drugs affect the synthesis and/or the secretion of collagenase. The results suggest that {"}first messengers{"} exist which can prevent the secretion of corneal collagenase by raising endogenous cAMP in corneal cells through stimulation of the adenyl cyclase system. Eventual successful treatment of corneal ulceration might well require pharmacologic intervention at multiple levels: the biosynthesis, secretion, activation and activity of collagenase.",

author = "Berman, {Michael B.} and Cavanagh, {H. Dwight} and Janet Gage",

year = "1976",

month = mar,

doi = "10.1016/0014-4835(76)90048-8",

language = "English (US)",

volume = "22",

pages = "209--218",

journal = "Experimental Eye Research",

issn = "0014-4835",

publisher = "Academic Press Inc.",

number = "3",

}

TY - JOUR

T1 - Regulation of collagenase activity in the ulcerating cornea by cyclic-AMP

AU - Berman, Michael B.

AU - Cavanagh, H. Dwight

AU - Gage, Janet

PY - 1976/3

Y1 - 1976/3

N2 - Dibutyryl cyclic-AMP (DBcAMP) and theophylline partially inhibit the appearance of collagenase activity when added to cultures of ulcerating rabbit corneas. Drug treatment with DBcAMP also inhibits degradation of collagen in the explanted corneas as measured by hydroxyproline in the media. The hydrolysis product of DBcAMP, 5′-adenosine monophosphate (5′ AMP) is itself very effective in suppressing collagenase activity and the degradation of explant collagen. The mechanism(s) of the drug effects is not yet known but it is possible that the drugs affect the synthesis and/or the secretion of collagenase. The results suggest that "first messengers" exist which can prevent the secretion of corneal collagenase by raising endogenous cAMP in corneal cells through stimulation of the adenyl cyclase system. Eventual successful treatment of corneal ulceration might well require pharmacologic intervention at multiple levels: the biosynthesis, secretion, activation and activity of collagenase.

AB - Dibutyryl cyclic-AMP (DBcAMP) and theophylline partially inhibit the appearance of collagenase activity when added to cultures of ulcerating rabbit corneas. Drug treatment with DBcAMP also inhibits degradation of collagen in the explanted corneas as measured by hydroxyproline in the media. The hydrolysis product of DBcAMP, 5′-adenosine monophosphate (5′ AMP) is itself very effective in suppressing collagenase activity and the degradation of explant collagen. The mechanism(s) of the drug effects is not yet known but it is possible that the drugs affect the synthesis and/or the secretion of collagenase. The results suggest that "first messengers" exist which can prevent the secretion of corneal collagenase by raising endogenous cAMP in corneal cells through stimulation of the adenyl cyclase system. Eventual successful treatment of corneal ulceration might well require pharmacologic intervention at multiple levels: the biosynthesis, secretion, activation and activity of collagenase.

UR - http://www.scopus.com/inward/record.url?scp=0017113087&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0017113087&partnerID=8YFLogxK

U2 - 10.1016/0014-4835(76)90048-8

DO - 10.1016/0014-4835(76)90048-8

M3 - Article

C2 - 178517

AN - SCOPUS:0017113087

SN - 0014-4835

VL - 22

SP - 209

EP - 218

JO - Experimental Eye Research

JF - Experimental Eye Research

IS - 3

ER -

Regulation of collagenase activity in the ulcerating cornea by cyclic-AMP

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this